TECON BIOLOGY Co.LTD
SZSE:002100.SZ
7.09 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 19,025.806 | 16,731.608 | 15,744.338 | 11,986.809 | 7,476.316 | 5,273.032 | 4,630.026 | 4,444.138 | 4,167.289 | 4,014.627 | 3,724.76 | 3,327.313 | 2,983.984 | 2,369.046 | 2,074.692 | 1,068.392 | 670.655 | 420.401 | 371.283 | 282.292 | 235.554 |
| Cost of Revenue
| 18,469.449 | 14,974.833 | 14,206.595 | 8,271.535 | 5,600.337 | 4,163.434 | 3,546.745 | 3,354.25 | 3,257.802 | 3,225.307 | 3,095.695 | 2,801.328 | 2,533.771 | 1,964.086 | 1,724.423 | 836.455 | 519.266 | 329.974 | 290.56 | 231.359 | 194.16 |
| Gross Profit
| 556.357 | 1,756.774 | 1,537.743 | 3,715.274 | 1,875.979 | 1,109.599 | 1,083.28 | 1,089.888 | 909.487 | 789.321 | 629.066 | 525.985 | 450.213 | 404.96 | 350.269 | 231.937 | 151.389 | 90.427 | 80.723 | 50.934 | 41.394 |
| Gross Profit Ratio
| 0.029 | 0.105 | 0.098 | 0.31 | 0.251 | 0.21 | 0.234 | 0.245 | 0.218 | 0.197 | 0.169 | 0.158 | 0.151 | 0.171 | 0.169 | 0.217 | 0.226 | 0.215 | 0.217 | 0.18 | 0.176 |
| Reseach & Development Expenses
| 257.232 | 181.062 | 142.89 | 103.986 | 84.886 | 78.65 | 53.893 | 77.529 | 60.418 | 74.761 | 60.373 | 56.771 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 398.783 | 125.041 | 433.156 | 328.254 | 142.725 | 102.632 | 83.211 | 95.546 | 115.039 | 74.66 | 62.383 | 59.836 | 41.571 | 34.393 | 109.619 | 70.742 | 58.776 | 23.855 | 25.005 | 13.688 | 11.327 |
| Selling & Marketing Expenses
| 543.057 | 475.206 | 527.452 | 694.332 | 545.822 | 312.936 | 273.818 | 282.578 | 315.122 | 284.054 | 239.498 | 207.519 | 176.145 | 124.677 | 106.533 | 55.367 | 29.967 | 15.983 | 18.05 | 10.998 | 9.261 |
| SG&A
| 941.84 | 600.247 | 960.608 | 1,022.586 | 688.547 | 415.568 | 357.029 | 378.124 | 430.161 | 358.714 | 301.882 | 267.355 | 217.716 | 159.069 | 216.151 | 126.109 | 88.743 | 39.838 | 43.055 | 24.686 | 20.588 |
| Other Expenses
| -46.931 | 326.826 | 424.396 | 559.852 | 342.98 | 1.186 | 2.859 | 45.4 | 32.7 | 14.753 | 10.332 | 14.471 | 10.199 | 11.322 | 6.163 | 4.661 | 11.124 | -1.109 | -0.22 | -0.102 | 0.312 |
| Operating Expenses
| 1,264.402 | 1,108.135 | 1,527.893 | 1,686.424 | 1,116.413 | 695.211 | 617.329 | 659.899 | 625.111 | 506.669 | 430.64 | 368.702 | 283.354 | 247.736 | 217.787 | 127.565 | 89.797 | 40.49 | 43.707 | 25.061 | 20.898 |
| Operating Income
| -1,446.038 | 660.16 | 6.981 | 1,808.132 | 800.164 | 333.228 | 425.75 | 387.297 | 240.411 | 216.056 | 173.177 | 119.74 | 80.742 | 114.403 | 105.815 | 83.455 | 46.903 | 39.178 | 27.059 | 20.617 | 17.267 |
| Operating Income Ratio
| -0.076 | 0.039 | 0 | 0.151 | 0.107 | 0.063 | 0.092 | 0.087 | 0.058 | 0.054 | 0.046 | 0.036 | 0.027 | 0.048 | 0.051 | 0.078 | 0.07 | 0.093 | 0.073 | 0.073 | 0.073 |
| Total Other Income Expenses Net
| -46.931 | -424.319 | -653.492 | -0.401 | -210.236 | -79.974 | -37.342 | -3.798 | -14.425 | -52.99 | -16.184 | -23.171 | -75.918 | -31.498 | -20.503 | -16.257 | -13.056 | -12.296 | -10.526 | -5.432 | -3.827 |
| Income Before Tax
| -1,492.968 | 235.841 | -646.511 | 1,807.731 | 589.928 | 334.414 | 428.609 | 426.191 | 269.951 | 229.661 | 182.242 | 134.112 | 90.942 | 125.725 | 111.978 | 88.116 | 48.536 | 37.855 | 26.664 | 20.478 | 17.124 |
| Income Before Tax Ratio
| -0.078 | 0.014 | -0.041 | 0.151 | 0.079 | 0.063 | 0.093 | 0.096 | 0.065 | 0.057 | 0.049 | 0.04 | 0.03 | 0.053 | 0.054 | 0.082 | 0.072 | 0.09 | 0.072 | 0.073 | 0.073 |
| Income Tax Expense
| 23.459 | 21.696 | 32.009 | 22.426 | -2.464 | 33.356 | 24.832 | 36.308 | 25.138 | 28.023 | 17.335 | 29.971 | 14.145 | 18.109 | 13.366 | 22.988 | 0.1 | -0.019 | 0.075 | 0.14 | -0.555 |
| Net Income
| -1,363.316 | 214.145 | -678.52 | 1,720.414 | 644.487 | 313.726 | 407.15 | 392.541 | 245.793 | 207.63 | 169.797 | 108.012 | 76.887 | 107.425 | 98.446 | 64.87 | 48.343 | 38.18 | 27.472 | 20.142 | 17.599 |
| Net Income Ratio
| -0.072 | 0.013 | -0.043 | 0.144 | 0.086 | 0.059 | 0.088 | 0.088 | 0.059 | 0.052 | 0.046 | 0.032 | 0.026 | 0.045 | 0.047 | 0.061 | 0.072 | 0.091 | 0.074 | 0.071 | 0.075 |
| EPS
| -1.01 | 0.16 | -0.62 | 1.61 | 0.61 | 0.33 | 0.42 | 0.41 | 0.27 | 0.27 | 0.21 | 0.14 | 0.1 | 0.14 | 0.14 | 0.11 | 0.074 | 0.12 | 0.056 | 0.041 | 0.036 |
| EPS Diluted
| -1.01 | 0.16 | -0.62 | 1.6 | 0.61 | 0.33 | 0.42 | 0.41 | 0.27 | 0.27 | 0.21 | 0.14 | 0.1 | 0.14 | 0.14 | 0.11 | 0.074 | 0.12 | 0.056 | 0.041 | 0.036 |
| EBITDA
| 104.991 | 1,373.35 | 711.928 | 2,523.916 | 1,116.958 | 652.356 | 654.094 | 656.188 | 526.886 | 387.787 | 325.525 | 256.339 | 256.133 | 208.908 | 179.915 | 134.666 | 84.679 | 65.53 | 46.489 | 32.204 | 25.445 |
| EBITDA Ratio
| 0.006 | 0.082 | 0.045 | 0.211 | 0.149 | 0.124 | 0.141 | 0.148 | 0.126 | 0.097 | 0.087 | 0.077 | 0.086 | 0.088 | 0.087 | 0.126 | 0.126 | 0.156 | 0.125 | 0.114 | 0.108 |